Previous 10 | Next 10 |
Gainers: [[MDLY]] +66.7%. [[KODK]] +13.5%. [[MDLX]] +12.2%. [[IDN]] +12.1%. [[OCX]] +11.7%.Losers: [[INO]] -8.5%. [[NTN]] -6.4%. [[TWST]] -5.8%. [[YQ]] -4.2%. [[ORC]] -4.2%. For further details see: MDLY, KODK, NTN and INO among after-hours movers
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. PTH: a growth ETF in healthcare. For further details see: Healthcare Review Starting In 2021 And Focus On PTH
Twist Bioscience ([[TWST]] +9.0%) has announced that its Biopharma division has signed two licensing agreements with Serotiny and Applied StemCell.With the Serotiny collaboration, Twist Biopharma aims to discover novel Chimeric Antigen Receptors for CAR T-Cell therapies, and it will ...
- Serotiny Agreement to Discover Novel Chimeric Antigen Receptors T-Cell Therapies - - Partners with Applied StemCell for TARGATT™ CHO Cell Technology - Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering o...
Twist Bioscience (TWST) has started shipping its new synthetic RNA reference controls, which includes the new variant strain of SARS-CoV-2 identified in the United Kingdom.“By offering synthetic controls for this specific mutation, our customers are able to update their testing pr...
-- RNA Controls Can Help Avoid False Negative Results -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its new s...
SKB finalizes new lease agreement with Twist Bioscience Corporation ("Twist") at recently repositioned mixed-use campus, ParkWorks Industrial Center PR Newswire PORTLAND, Ore. , Jan. 11, 2021 /PRNewswire/ -- ScanlanKemperBard (SKB), General Partner of PW Ven...
Twist Bioscience (TWST) will supply the U.S. Centers for Disease Control and Prevention ((CDC)) with a customized version of Twist SARS-CoV-2 Synthetic RNA Controls for use in the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay. The Flu SC2 Multiplex Assay tests for influenza A, B and be u...
Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it will supply the U.S. Centers for Disease Control and Prevention (CDC) with a customized version of Twist...
The iShares Nasdaq Biotechnology ETF includes both COVID-19 and other plays. The ETF is up by 26% during the last year and there are questions around further growth. While some analysts have a neutral stance, there are some indications which point to more upside, despite uncertain...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...